[
  {
    "ts": null,
    "headline": "Government Shutdown, Government Shmutdown",
    "summary": "Market indexes were ultimately unbothered by this latest federal government shutdown today, to say nothing of the negative private-sector payroll report this morning.",
    "url": "https://finnhub.io/api/news?id=b40d8710fadd7885069d82bacd7bc9f5e081cb6f06cb5c47f9932698a7301988",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759358700,
      "headline": "Government Shutdown, Government Shmutdown",
      "id": 136952345,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Market indexes were ultimately unbothered by this latest federal government shutdown today, to say nothing of the negative private-sector payroll report this morning.",
      "url": "https://finnhub.io/api/news?id=b40d8710fadd7885069d82bacd7bc9f5e081cb6f06cb5c47f9932698a7301988"
    }
  },
  {
    "ts": null,
    "headline": "Why BioNTech Stock Jumped by Nearly 4% on Wednesday",
    "summary": "The company's push deeper into a hot new technology, plus good news from a top collaborator, put the shine on its equity.",
    "url": "https://finnhub.io/api/news?id=1b3685e8594d9141f55b1fc2bcd9cfb7111d60cfe52a571c71c8d6ed74ba9afb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759356813,
      "headline": "Why BioNTech Stock Jumped by Nearly 4% on Wednesday",
      "id": 136952346,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The company's push deeper into a hot new technology, plus good news from a top collaborator, put the shine on its equity.",
      "url": "https://finnhub.io/api/news?id=1b3685e8594d9141f55b1fc2bcd9cfb7111d60cfe52a571c71c8d6ed74ba9afb"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (PFE) Soars on Tariff Exemption, Landmark US Govt Deal",
    "summary": "We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Pfizer Inc. (NYSE:PFE) is one of the top performers on Tuesday. Pfizer Inc. extended its winning streak to a third straight day on Tuesday, jumping 6.83 percent to close at $25.48 apiece as investors cheered its exception from the US government’s imposition of 100 […]",
    "url": "https://finnhub.io/api/news?id=095cd35916483d992f40e4174301dde78f6844ded7c57c4c7f79ec5e5fa5b075",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759354596,
      "headline": "Pfizer (PFE) Soars on Tariff Exemption, Landmark US Govt Deal",
      "id": 136952347,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Pfizer Inc. (NYSE:PFE) is one of the top performers on Tuesday. Pfizer Inc. extended its winning streak to a third straight day on Tuesday, jumping 6.83 percent to close at $25.48 apiece as investors cheered its exception from the US government’s imposition of 100 […]",
      "url": "https://finnhub.io/api/news?id=095cd35916483d992f40e4174301dde78f6844ded7c57c4c7f79ec5e5fa5b075"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer Stock Trounced the Market Today",
    "summary": "A bullish analyst note added to the generally good sentiment on the company.",
    "url": "https://finnhub.io/api/news?id=fe7a10627152d167c349e9bd931e14adc353f50ebd668ec8ce7ff20eca412711",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352922,
      "headline": "Why Pfizer Stock Trounced the Market Today",
      "id": 136952348,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "A bullish analyst note added to the generally good sentiment on the company.",
      "url": "https://finnhub.io/api/news?id=fe7a10627152d167c349e9bd931e14adc353f50ebd668ec8ce7ff20eca412711"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
    "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
    "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352755,
      "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
      "id": 136951001,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
      "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
    "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
    "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352100,
      "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
      "id": 136952143,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
      "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Rise as Healthcare Jumps, October Rate-Cut Certainty Increases Amid Surprise Fall in Private Payrolls",
    "summary": "US equity indexes rose at the close on Wednesday amid gains in healthcare and increasing bets favori",
    "url": "https://finnhub.io/api/news?id=2773ac517cad9f7334b97c8ca3bc6e16ed94b3b558af0a0f32ccb9433f36b485",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759351970,
      "headline": "US Equity Indexes Rise as Healthcare Jumps, October Rate-Cut Certainty Increases Amid Surprise Fall in Private Payrolls",
      "id": 136952242,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US equity indexes rose at the close on Wednesday amid gains in healthcare and increasing bets favori",
      "url": "https://finnhub.io/api/news?id=2773ac517cad9f7334b97c8ca3bc6e16ed94b3b558af0a0f32ccb9433f36b485"
    }
  },
  {
    "ts": null,
    "headline": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
    "summary": "Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday.",
    "url": "https://finnhub.io/api/news?id=bac3ddf7c37b22aa4b4c87ef97f323b201820218df4a801e903b13c033162193",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320030,
      "headline": "Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff",
      "id": 136947208,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Drug stocks are celebrating in the wake of Trump's threat to levy a 100% tariff on pharmaceutical imports starting Wednesday.",
      "url": "https://finnhub.io/api/news?id=bac3ddf7c37b22aa4b4c87ef97f323b201820218df4a801e903b13c033162193"
    }
  },
  {
    "ts": null,
    "headline": "Trump-Pfizer deal could fuel pharma stock rally, advisor says",
    "summary": "STORY: European and U.S. healthcare stocks surged on Wednesday, propelled by a deal between Pfizer and President Donald Trump to lower prescription drug prices in the Medicaid program in exchange for tariff relief.The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of clarity after a volatile year during which Trump has taken aim at the sector over high U.S. medicine prices.While Orczyk Sissel said the deal \"may not necessarily be great for their overall profitability,\" the drug companies' are now \"in a position to start to have better visibility on their earnings... without the pricing pressures that they formerly had.\"",
    "url": "https://finnhub.io/api/news?id=5ee22b065c8775a180ea6181625663ed406e23f8fd97226d39e26e9375e6e699",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759349591,
      "headline": "Trump-Pfizer deal could fuel pharma stock rally, advisor says",
      "id": 136952353,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "STORY: European and U.S. healthcare stocks surged on Wednesday, propelled by a deal between Pfizer and President Donald Trump to lower prescription drug prices in the Medicaid program in exchange for tariff relief.The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of clarity after a volatile year during which Trump has taken aim at the sector over high U.S. medicine prices.While Orczyk Sissel said the deal \"may not necessarily be great for their overall profitability,\" the drug companies' are now \"in a position to start to have better visibility on their earnings... without the pricing pressures that they formerly had.\"",
      "url": "https://finnhub.io/api/news?id=5ee22b065c8775a180ea6181625663ed406e23f8fd97226d39e26e9375e6e699"
    }
  },
  {
    "ts": null,
    "headline": "Why AbbVie (ABBV) Stock Is Trading Up Today",
    "summary": "Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 5.2% in the afternoon session after the company submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for its drug candidate pivekimab sunirine. The company is developing the molecule as a potential treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and highly aggressive blood cancer, as well as acute myeloid leukemia (AML). Investor optimism was further bolstered by AbbVie",
    "url": "https://finnhub.io/api/news?id=0bca266385a251b952a1b7183256ddbcec174ee33956b13388248144a702acf7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348870,
      "headline": "Why AbbVie (ABBV) Stock Is Trading Up Today",
      "id": 136952020,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 5.2% in the afternoon session after the company submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for its drug candidate pivekimab sunirine. The company is developing the molecule as a potential treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and highly aggressive blood cancer, as well as acute myeloid leukemia (AML). Investor optimism was further bolstered by AbbVie",
      "url": "https://finnhub.io/api/news?id=0bca266385a251b952a1b7183256ddbcec174ee33956b13388248144a702acf7"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Pfizer (PFE) Stock Soaring Today",
    "summary": "Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 7.2% in the afternoon session after the company announced a landmark agreement with the U.S. government aimed at lowering prescription drug prices for American patients.",
    "url": "https://finnhub.io/api/news?id=b471afd8b4372bacdf2607efaac4c5a58bb4912e2e4badefce791dce8096dfec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348864,
      "headline": "Why Is Pfizer (PFE) Stock Soaring Today",
      "id": 136952355,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 7.2% in the afternoon session after the company announced a landmark agreement with the U.S. government aimed at lowering prescription drug prices for American patients.",
      "url": "https://finnhub.io/api/news?id=b471afd8b4372bacdf2607efaac4c5a58bb4912e2e4badefce791dce8096dfec"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Eli Lilly (LLY) Stock Rocketing Higher Today",
    "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.6% in the afternoon session after the stock's positive momentum continued as the White House revealed plans to launch a website for consumers to purchase drugs from manufacturers at a discount, providing clarity for the pharmaceutical industry on future pricing policies. The positive sentiment was bolstered by news that competitor Pfizer had already secured a deal to lower some of its U.S. drug prices. Following this, Eli Lill",
    "url": "https://finnhub.io/api/news?id=81347767ccf84273084dc94aff1d1234b7d2cd68af6035a8f8ca2ac423ab0505",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348860,
      "headline": "Why Is Eli Lilly (LLY) Stock Rocketing Higher Today",
      "id": 136952144,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 8.6% in the afternoon session after the stock's positive momentum continued as the White House revealed plans to launch a website for consumers to purchase drugs from manufacturers at a discount, providing clarity for the pharmaceutical industry on future pricing policies. The positive sentiment was bolstered by news that competitor Pfizer had already secured a deal to lower some of its U.S. drug prices. Following this, Eli Lill",
      "url": "https://finnhub.io/api/news?id=81347767ccf84273084dc94aff1d1234b7d2cd68af6035a8f8ca2ac423ab0505"
    }
  },
  {
    "ts": null,
    "headline": "Why Merck (MRK) Stock Is Up Today",
    "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.",
    "url": "https://finnhub.io/api/news?id=486fce15972b9fed8e3956ff090de0e7fa1db96758b3a92330e210d6b93ed58a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348850,
      "headline": "Why Merck (MRK) Stock Is Up Today",
      "id": 136951004,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.",
      "url": "https://finnhub.io/api/news?id=486fce15972b9fed8e3956ff090de0e7fa1db96758b3a92330e210d6b93ed58a"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins",
    "summary": "US equity indexes rose ahead of the close on Wednesday amid strong gains in the healthcare sector an",
    "url": "https://finnhub.io/api/news?id=26f967bc0e65373ca871110fb9a6f5a71e2f2cb3b47c5951634e8317d6bd24b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348643,
      "headline": "Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins",
      "id": 136952244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US equity indexes rose ahead of the close on Wednesday amid strong gains in the healthcare sector an",
      "url": "https://finnhub.io/api/news?id=26f967bc0e65373ca871110fb9a6f5a71e2f2cb3b47c5951634e8317d6bd24b4"
    }
  },
  {
    "ts": null,
    "headline": "Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.",
    "summary": "The surge in pharmaceutical stocks that followed the administration’s deal with Pfizer on Tuesday was still going strong on Wednesday.",
    "url": "https://finnhub.io/api/news?id=13f5eb24fffe0cf0e1dabf1387b42196ba46fe57fd37f6076214bb13b7713c62",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759346340,
      "headline": "Trump Triggered a Rally in Drug Stocks. Why It Might Not Last.",
      "id": 136952146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The surge in pharmaceutical stocks that followed the administration’s deal with Pfizer on Tuesday was still going strong on Wednesday.",
      "url": "https://finnhub.io/api/news?id=13f5eb24fffe0cf0e1dabf1387b42196ba46fe57fd37f6076214bb13b7713c62"
    }
  },
  {
    "ts": null,
    "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
    "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
    "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759343791,
      "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
      "id": 136951005,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
      "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7"
    }
  },
  {
    "ts": null,
    "headline": "Another Surging Pharma Stock to Watch Right Now",
    "summary": "Pharmaceutical stocks have been surging the past two sessions",
    "url": "https://finnhub.io/api/news?id=81f2d37d329f244eaaa45cf23e9fd653e41654399248f524c9fa2177b9c0868c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759341210,
      "headline": "Another Surging Pharma Stock to Watch Right Now",
      "id": 136952149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks have been surging the past two sessions",
      "url": "https://finnhub.io/api/news?id=81f2d37d329f244eaaa45cf23e9fd653e41654399248f524c9fa2177b9c0868c"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins",
    "summary": "US equity indexes were mixed in midday trading on Wednesday as healthcare helped offset losses, whil",
    "url": "https://finnhub.io/api/news?id=61675de07f152141193b70daa10b4e4341d46e83bbed41139e9ff6a4533b822a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759340871,
      "headline": "US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins",
      "id": 136952246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US equity indexes were mixed in midday trading on Wednesday as healthcare helped offset losses, whil",
      "url": "https://finnhub.io/api/news?id=61675de07f152141193b70daa10b4e4341d46e83bbed41139e9ff6a4533b822a"
    }
  },
  {
    "ts": null,
    "headline": "America’s Pharmacist in Chief",
    "summary": "America’s Pharmacist in Chief",
    "url": "https://finnhub.io/api/news?id=70d195699d980693522266639c9a0c6b45e067cab7c78c2bf94570087d653179",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759339800,
      "headline": "America’s Pharmacist in Chief",
      "id": 137016824,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "America’s Pharmacist in Chief",
      "url": "https://finnhub.io/api/news?id=70d195699d980693522266639c9a0c6b45e067cab7c78c2bf94570087d653179"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income",
    "summary": "Pfizer Inc. (NYSE:PFE) is included among the 10 Highest Dividend-Paying Stocks to Buy in the S&P 500. Pfizer Inc. (NYSE:PFE) is a US pharmaceutical and biotech giant that provides various allied products and services to its customers. In recent years, the company has made several moves to fill its drug pipeline, most notably its $43 billion […]",
    "url": "https://finnhub.io/api/news?id=d328f45ef0d25618377620bde324b4b7e463798637899e59afa64d1a3fbb548a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759338555,
      "headline": "Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income",
      "id": 136947456,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) is included among the 10 Highest Dividend-Paying Stocks to Buy in the S&P 500. Pfizer Inc. (NYSE:PFE) is a US pharmaceutical and biotech giant that provides various allied products and services to its customers. In recent years, the company has made several moves to fill its drug pipeline, most notably its $43 billion […]",
      "url": "https://finnhub.io/api/news?id=d328f45ef0d25618377620bde324b4b7e463798637899e59afa64d1a3fbb548a"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Rallies as Traders Digest Pfizer Deal -- Health Care Roundup",
    "summary": "Health Care Rallies as Traders Digest Pfizer Deal -- Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=8f24ecf802f1dc3d89c25721f94c74911688b5c8d20a1b2e5b4a6d4ed9c2fd45",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759338480,
      "headline": "Health Care Rallies as Traders Digest Pfizer Deal -- Health Care Roundup",
      "id": 137110320,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Health Care Rallies as Traders Digest Pfizer Deal -- Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=8f24ecf802f1dc3d89c25721f94c74911688b5c8d20a1b2e5b4a6d4ed9c2fd45"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Climbs To Multi-Month High On Trump Drug Pricing Breakthrough",
    "summary": "Trump Launches TrumpRx Website, Pfizer Jumps On Discount Drug Pact",
    "url": "https://finnhub.io/api/news?id=f118413b8c5526067b9ccb26a58c723fc8c2d0f21a00211ef728d3aad7874e21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759337573,
      "headline": "Pfizer Stock Climbs To Multi-Month High On Trump Drug Pricing Breakthrough",
      "id": 136947457,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Trump Launches TrumpRx Website, Pfizer Jumps On Discount Drug Pact",
      "url": "https://finnhub.io/api/news?id=f118413b8c5526067b9ccb26a58c723fc8c2d0f21a00211ef728d3aad7874e21"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More",
    "summary": "Pharmaceutical stocks gained Wednesday afternoon amid anticipation Pfizer's deal with the Trump administration could lead to more with other firms.",
    "url": "https://finnhub.io/api/news?id=53f0874c88d2e08bf49dd7ec378ed52854f845339df094421fccff0eaa9ed8b5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759336541,
      "headline": "Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More",
      "id": 136947201,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pharmaceutical stocks gained Wednesday afternoon amid anticipation Pfizer's deal with the Trump administration could lead to more with other firms.",
      "url": "https://finnhub.io/api/news?id=53f0874c88d2e08bf49dd7ec378ed52854f845339df094421fccff0eaa9ed8b5"
    }
  },
  {
    "ts": null,
    "headline": "FTSE 100 hits another high despite concerns over US government shutdown",
    "summary": "Drug companies AstraZeneca, Hikma Pharmaceuticals and GSK were all big risers.",
    "url": "https://finnhub.io/api/news?id=62752f37ef914efefc90981f0d4a39509a350e1c29d9160551a77cb4d362dceb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759336218,
      "headline": "FTSE 100 hits another high despite concerns over US government shutdown",
      "id": 136947459,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Drug companies AstraZeneca, Hikma Pharmaceuticals and GSK were all big risers.",
      "url": "https://finnhub.io/api/news?id=62752f37ef914efefc90981f0d4a39509a350e1c29d9160551a77cb4d362dceb"
    }
  },
  {
    "ts": null,
    "headline": "Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks",
    "summary": "Yahoo Finance anchor Julie Hyman outlines some of the biggest stories as part of this Market Minute, including pharmaceutical stocks rising on Pfizer's (PFE) tariff deal with the Trump administration, Reddit (RDDT) stock sinking as new data shows that the number of ChatGPT's (OPAI.PVT) responses referencing Reddit content has declined, and Jefferies' bullish Sunrun (RUN) call. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=924ce6709fdd7f3299136f8a717717617a9b0625410a2b15fe550f29c27bdb05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759335450,
      "headline": "Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks",
      "id": 136947202,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Yahoo Finance anchor Julie Hyman outlines some of the biggest stories as part of this Market Minute, including pharmaceutical stocks rising on Pfizer's (PFE) tariff deal with the Trump administration, Reddit (RDDT) stock sinking as new data shows that the number of ChatGPT's (OPAI.PVT) responses referencing Reddit content has declined, and Jefferies' bullish Sunrun (RUN) call. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=924ce6709fdd7f3299136f8a717717617a9b0625410a2b15fe550f29c27bdb05"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock, Other Drugmakers Rally Again",
    "summary": "After its best day in nearly four years Tuesday, Pfizer stock is giving an encore performance. Shares of the drugmaker are up 5.5% in midday trading as investors digest yesterday's news that Pfizer would get a three-year exemption from national-security-related tariffs, in return for domestic manufacturing investments and Pfizer's participation in a government-run website called TrumpRx.",
    "url": "https://finnhub.io/api/news?id=3d4f225276ac87a5c85b10c4e7ba33633e09007d4b366cd4c04200e8c17b96b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759333445,
      "headline": "Pfizer Stock, Other Drugmakers Rally Again",
      "id": 136947203,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "After its best day in nearly four years Tuesday, Pfizer stock is giving an encore performance. Shares of the drugmaker are up 5.5% in midday trading as investors digest yesterday's news that Pfizer would get a three-year exemption from national-security-related tariffs, in return for domestic manufacturing investments and Pfizer's participation in a government-run website called TrumpRx.",
      "url": "https://finnhub.io/api/news?id=3d4f225276ac87a5c85b10c4e7ba33633e09007d4b366cd4c04200e8c17b96b4"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know",
    "summary": "Pfizer's CEO says the deal with the Trump administration is \"a win\" for the company. He's probably right.",
    "url": "https://finnhub.io/api/news?id=46265c01e669262ec86f968067cf74f063ce62c0d9907925968eb14c2cf4dcc5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759333329,
      "headline": "Pfizer Just Announced a Massive Deal with TrumpRx. Here's What Investors Need to Know",
      "id": 136947462,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's CEO says the deal with the Trump administration is \"a win\" for the company. He's probably right.",
      "url": "https://finnhub.io/api/news?id=46265c01e669262ec86f968067cf74f063ce62c0d9907925968eb14c2cf4dcc5"
    }
  },
  {
    "ts": null,
    "headline": "What is TrumpRx? Pfizer, Trump deal includes new direct to consumer website announcement",
    "summary": "President Donald Trump announced a deal with Pfizer to lower drug prices for some Americans. The White House is also unveiling a TrumpRx website.",
    "url": "https://finnhub.io/api/news?id=dd554d34ecbe66a2e9243676b2e50e23ba2f23a475f084cc46be460b7812088d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759333209,
      "headline": "What is TrumpRx? Pfizer, Trump deal includes new direct to consumer website announcement",
      "id": 136947463,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "President Donald Trump announced a deal with Pfizer to lower drug prices for some Americans. The White House is also unveiling a TrumpRx website.",
      "url": "https://finnhub.io/api/news?id=dd554d34ecbe66a2e9243676b2e50e23ba2f23a475f084cc46be460b7812088d"
    }
  },
  {
    "ts": null,
    "headline": "All Cap Investing With Kirk Spano",
    "summary": "Kirk Spano runs Margin of Safety Investing and shares what this moment means for all cap investors. Using options, covered calls.",
    "url": "https://finnhub.io/api/news?id=8791af52a3096427d13adc649c16e421f787043433d1e4dd8f1271517ee62e03",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759332000,
      "headline": "All Cap Investing With Kirk Spano",
      "id": 136949048,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2176550830/image_2176550830.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Kirk Spano runs Margin of Safety Investing and shares what this moment means for all cap investors. Using options, covered calls.",
      "url": "https://finnhub.io/api/news?id=8791af52a3096427d13adc649c16e421f787043433d1e4dd8f1271517ee62e03"
    }
  },
  {
    "ts": null,
    "headline": "Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End",
    "summary": "FEATURE  Healthcare stocks have found a second wind, with momentum building across biotech and pharmaceuticals.  The cleared the very round $100 level for the first time in 10 months yesterday. The more pharma-specific surged 3.",
    "url": "https://finnhub.io/api/news?id=fcaea91725db69ea6ff5513a4aa5f0b3ea2968ca11f38eac9e1d0fc75987a454",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759331400,
      "headline": "Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End",
      "id": 136947245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "FEATURE  Healthcare stocks have found a second wind, with momentum building across biotech and pharmaceuticals.  The cleared the very round $100 level for the first time in 10 months yesterday. The more pharma-specific surged 3.",
      "url": "https://finnhub.io/api/news?id=fcaea91725db69ea6ff5513a4aa5f0b3ea2968ca11f38eac9e1d0fc75987a454"
    }
  },
  {
    "ts": null,
    "headline": "Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?",
    "summary": "ALNY's portfolio of rare disease and cardiovascular drugs is boosting revenues and reducing reliance on Amvuttra.",
    "url": "https://finnhub.io/api/news?id=322fa7c40c4d8fac54990a5e3590aa0c97dfcc1af79e280086439c0c288feee7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759331100,
      "headline": "Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?",
      "id": 136947465,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "ALNY's portfolio of rare disease and cardiovascular drugs is boosting revenues and reducing reliance on Amvuttra.",
      "url": "https://finnhub.io/api/news?id=322fa7c40c4d8fac54990a5e3590aa0c97dfcc1af79e280086439c0c288feee7"
    }
  },
  {
    "ts": null,
    "headline": "Q: Will TrumpRx and ‘Most Favored Nation’ Deals Save Americans Money?",
    "summary": "A: Pfizer is the first drugmaker to reach an agreement with the White House that includes selling its drugs to Medicaid at the lowest price available to other developed countries, the “most-favored-nation” price.  Most Americans enrolled in health plans will likely save more money using their insurance.  For Medicaid patients, it is unclear whether the “most favored nation” pricing will be lower than what the program currently pays.",
    "url": "https://finnhub.io/api/news?id=f87470901d1b48e64f742dd1c75e88cf230248dcd282d7a633a839623e87d40c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759330997,
      "headline": "Q: Will TrumpRx and ‘Most Favored Nation’ Deals Save Americans Money?",
      "id": 136947204,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "A: Pfizer is the first drugmaker to reach an agreement with the White House that includes selling its drugs to Medicaid at the lowest price available to other developed countries, the “most-favored-nation” price.  Most Americans enrolled in health plans will likely save more money using their insurance.  For Medicaid patients, it is unclear whether the “most favored nation” pricing will be lower than what the program currently pays.",
      "url": "https://finnhub.io/api/news?id=f87470901d1b48e64f742dd1c75e88cf230248dcd282d7a633a839623e87d40c"
    }
  },
  {
    "ts": null,
    "headline": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
    "summary": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
    "url": "https://finnhub.io/api/news?id=279c6d25b27495907ff20e46c94ee722f328cb615bb6baba85a2a6448ba0eadf",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759330136,
      "headline": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
      "id": 136995478,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pharma stocks are powering the Nasdaq Composite and S&P 500 higher in afternoon trading",
      "url": "https://finnhub.io/api/news?id=279c6d25b27495907ff20e46c94ee722f328cb615bb6baba85a2a6448ba0eadf"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental",
    "summary": "↗️ Lithium Americas (LAC): The U.S. government said Tuesday it would take a 5% stake in both the Canadian company and its Nevada mining project. Shares jumped by roughly one-third in premarket trading.",
    "url": "https://finnhub.io/api/news?id=0c07d91dfc9d3e0294361190c520161e7d11d3f8d6816c7d27813c5f3214b964",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759309518,
      "headline": "Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental",
      "id": 136944164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "↗️ Lithium Americas (LAC): The U.S. government said Tuesday it would take a 5% stake in both the Canadian company and its Nevada mining project. Shares jumped by roughly one-third in premarket trading.",
      "url": "https://finnhub.io/api/news?id=0c07d91dfc9d3e0294361190c520161e7d11d3f8d6816c7d27813c5f3214b964"
    }
  },
  {
    "ts": null,
    "headline": "Is the U.S. drug pricing deal good for Pfizer?",
    "summary": "Investing.com -- Pfizer and U.S. President Donald Trump on Tuesday unveiled a deal under which the drugmaker will cut Medicaid prescription drug prices to match those charged in other developed markets in exchange for tariff relief.",
    "url": "https://finnhub.io/api/news?id=57a41627a0f6d9634465973c27e69b216d9cb0589da441fc33b85364e0b9a9e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759325530,
      "headline": "Is the U.S. drug pricing deal good for Pfizer?",
      "id": 136947468,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investing.com -- Pfizer and U.S. President Donald Trump on Tuesday unveiled a deal under which the drugmaker will cut Medicaid prescription drug prices to match those charged in other developed markets in exchange for tariff relief.",
      "url": "https://finnhub.io/api/news?id=57a41627a0f6d9634465973c27e69b216d9cb0589da441fc33b85364e0b9a9e4"
    }
  },
  {
    "ts": null,
    "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
    "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
    "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759325460,
      "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
      "id": 136947247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
      "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market News for Oct 1, 2025",
    "summary": "Wall Street closed higher on Tuesday, driven by healthcare stocks.",
    "url": "https://finnhub.io/api/news?id=692623bfe06a30c36b0e1a4cb3ee9803a2acf7c087c14079fba82ca723e204a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759324920,
      "headline": "Stock Market News for Oct 1, 2025",
      "id": 136947206,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Wall Street closed higher on Tuesday, driven by healthcare stocks.",
      "url": "https://finnhub.io/api/news?id=692623bfe06a30c36b0e1a4cb3ee9803a2acf7c087c14079fba82ca723e204a0"
    }
  },
  {
    "ts": null,
    "headline": "SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY",
    "summary": "Shasqi, Inc. (\"Shasqi\") a biotech company whose mission is to make cancer drugs more effective with pre-targeting enabled by click chemistry, today announced the appointment of Roger Dansey, M.D., a prominent leader in oncology research and drug development, to its Board of Directors.",
    "url": "https://finnhub.io/api/news?id=d1f23ac3bea0ae261e401a99c42b7b53d2288eb5a95d9167fa6e65ce5b2967bd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759323600,
      "headline": "SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY",
      "id": 136947471,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shasqi, Inc. (\"Shasqi\") a biotech company whose mission is to make cancer drugs more effective with pre-targeting enabled by click chemistry, today announced the appointment of Roger Dansey, M.D., a prominent leader in oncology research and drug development, to its Board of Directors.",
      "url": "https://finnhub.io/api/news?id=d1f23ac3bea0ae261e401a99c42b7b53d2288eb5a95d9167fa6e65ce5b2967bd"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Fall Pre-Bell as US Government Shuts Down",
    "summary": "The main US stock measures were pointing lower in Wednesday's premarket activity after the federal g",
    "url": "https://finnhub.io/api/news?id=19484a70d80cb76168438584011c3c6b2739df4bdb93a87b4157e2b3ccceeffa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320667,
      "headline": "Stocks Fall Pre-Bell as US Government Shuts Down",
      "id": 136945503,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The main US stock measures were pointing lower in Wednesday's premarket activity after the federal g",
      "url": "https://finnhub.io/api/news?id=19484a70d80cb76168438584011c3c6b2739df4bdb93a87b4157e2b3ccceeffa"
    }
  },
  {
    "ts": null,
    "headline": "European healthcare stocks surge after US deal with Pfizer",
    "summary": "STORY: European healthcare stocks jumped on Wednesday, mirroring moves in the United States.It comes a day after U.S.-based drugmaker Pfizer and President Donald Trump announced an agreement to lower prescription drug prices in the Medicaid program in exchange for tariff relief.Healthcare stocks in the U.S. and Europe have been lagging this year as a result of uncertainty about the Trump administration's stance on drug pricing.Analysts said the Pfizer deal had reduced uncertainty for the sector.Trump sent letters to 17 leading drug companies in July telling them to slash prices to match those paid overseas.Pfizer is the first to announce a deal.Europe's healthcare sector index rose 2.77%, which if sustained would be its biggest daily percentage gain since April.AstraZeneca, Ambu, Merck and Sartorius were among those to climb.Pfizer shares rose 7% on Tuesday, and other U.S. pharma stocks also gained.",
    "url": "https://finnhub.io/api/news?id=e1362238af10635517926371f8ccb72fe98564dab92da9c050e5389996232440",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320399,
      "headline": "European healthcare stocks surge after US deal with Pfizer",
      "id": 136945743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "STORY: European healthcare stocks jumped on Wednesday, mirroring moves in the United States.It comes a day after U.S.-based drugmaker Pfizer and President Donald Trump announced an agreement to lower prescription drug prices in the Medicaid program in exchange for tariff relief.Healthcare stocks in the U.S. and Europe have been lagging this year as a result of uncertainty about the Trump administration's stance on drug pricing.Analysts said the Pfizer deal had reduced uncertainty for the sector.Trump sent letters to 17 leading drug companies in July telling them to slash prices to match those paid overseas.Pfizer is the first to announce a deal.Europe's healthcare sector index rose 2.77%, which if sustained would be its biggest daily percentage gain since April.AstraZeneca, Ambu, Merck and Sartorius were among those to climb.Pfizer shares rose 7% on Tuesday, and other U.S. pharma stocks also gained.",
      "url": "https://finnhub.io/api/news?id=e1362238af10635517926371f8ccb72fe98564dab92da9c050e5389996232440"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma's big boost: Market Movers",
    "summary": "Pharma giants in the US had a massive boost after Pfizer (PFE) avoided tariffs by coming to an agreement with Donald Trump to sell drugs directly to the American people at a lower price. Domestic competitors Eli Lilly (LLY) and Merck (MRK) are expected to follow suit, as Pfizer also announced $70 billion dollars worth of investment in the US. The ripple effects were also felt in Europe and beyond. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.",
    "url": "https://finnhub.io/api/news?id=1ce3ee5a61ff50b2d2825bb52f238f67de975bb396f5471aa4a46561797f862a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320182,
      "headline": "Big Pharma's big boost: Market Movers",
      "id": 136947207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pharma giants in the US had a massive boost after Pfizer (PFE) avoided tariffs by coming to an agreement with Donald Trump to sell drugs directly to the American people at a lower price. Domestic competitors Eli Lilly (LLY) and Merck (MRK) are expected to follow suit, as Pfizer also announced $70 billion dollars worth of investment in the US. The ripple effects were also felt in Europe and beyond. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.",
      "url": "https://finnhub.io/api/news?id=1ce3ee5a61ff50b2d2825bb52f238f67de975bb396f5471aa4a46561797f862a"
    }
  },
  {
    "ts": null,
    "headline": "C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma",
    "summary": "WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer Inc. Under the terms of the agreement, Pfizer will supply elranatamab (ELREXFIO®), a B-cell maturation antigen CD3 targeted bispecific antibody (BCMAxCD3 bispecific), to C4T for its upcoming Phas",
    "url": "https://finnhub.io/api/news?id=2e1901f2e411060c503c33f7beb8d65edd80e82482a500591a45b80ca39a93b8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759316400,
      "headline": "C4 Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Pfizer for the Combination of Cemsidomide and Elranatamab for the Treatment of Relapsed/Refractory Multiple Myeloma",
      "id": 136944240,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "WATERTOWN, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer Inc. Under the terms of the agreement, Pfizer will supply elranatamab (ELREXFIO®), a B-cell maturation antigen CD3 targeted bispecific antibody (BCMAxCD3 bispecific), to C4T for its upcoming Phas",
      "url": "https://finnhub.io/api/news?id=2e1901f2e411060c503c33f7beb8d65edd80e82482a500591a45b80ca39a93b8"
    }
  },
  {
    "ts": null,
    "headline": "Health Care Roundup: Market Talk",
    "summary": "0753 GMT – Pfizer’s agreement with the Trump administration brings clarity in terms of tariff and drug pricing for the pharmaceutical industry and other big pharma companies could follow suit, analysts at Berenberg say in a research note.  Pfizer made the first move to address the Trump administration’s requests to match U.S. drug prices with the rest of the world, Berenberg says.  The U.S. drugmaker pledged to lower the price of all medicines sold via Medicaid to reflect those in other developed nations and to offer medicines through a government-run website dubbed TrumpRx.",
    "url": "https://finnhub.io/api/news?id=d4aa9a97b19c156a9e252de9708ca8961b0aeaeca718471c2e1916dc1a11c52f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759314060,
      "headline": "Health Care Roundup: Market Talk",
      "id": 136944241,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "0753 GMT – Pfizer’s agreement with the Trump administration brings clarity in terms of tariff and drug pricing for the pharmaceutical industry and other big pharma companies could follow suit, analysts at Berenberg say in a research note.  Pfizer made the first move to address the Trump administration’s requests to match U.S. drug prices with the rest of the world, Berenberg says.  The U.S. drugmaker pledged to lower the price of all medicines sold via Medicaid to reflect those in other developed nations and to offer medicines through a government-run website dubbed TrumpRx.",
      "url": "https://finnhub.io/api/news?id=d4aa9a97b19c156a9e252de9708ca8961b0aeaeca718471c2e1916dc1a11c52f"
    }
  },
  {
    "ts": null,
    "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
    "summary": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
    "url": "https://finnhub.io/api/news?id=a4e04cdc235f20ebb03633aa05fb75eda0611f0b148ce2199bd524b7919f032d",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759312884,
      "headline": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
      "id": 136995450,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "What TrumpRx Means For Controversial Plan To Lower U.S. Drug Prices",
      "url": "https://finnhub.io/api/news?id=a4e04cdc235f20ebb03633aa05fb75eda0611f0b148ce2199bd524b7919f032d"
    }
  },
  {
    "ts": null,
    "headline": "Better AI Dividend Stock: Apple vs. Broadcom",
    "summary": "These two AI titans have started paying dividends. Which is the better stock for dividend investors?",
    "url": "https://finnhub.io/api/news?id=1f2e72915e52e689eced53f5299944cdc37a4a7554f43dd77b4a2a6de31a15e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759311300,
      "headline": "Better AI Dividend Stock: Apple vs. Broadcom",
      "id": 136943877,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "These two AI titans have started paying dividends. Which is the better stock for dividend investors?",
      "url": "https://finnhub.io/api/news?id=1f2e72915e52e689eced53f5299944cdc37a4a7554f43dd77b4a2a6de31a15e4"
    }
  },
  {
    "ts": null,
    "headline": "How Trump’s Drug-Buying Site ‘TrumpRx’ Will Work",
    "summary": "If you are among the 90% of Americans who have health insurance, it’s unlikely to save you much money.",
    "url": "https://finnhub.io/api/news?id=680df2da50e21b1107666dc1a2a060c3ed6ef4767f9bbee22c0d13c5c2777d99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759311000,
      "headline": "How Trump’s Drug-Buying Site ‘TrumpRx’ Will Work",
      "id": 136944243,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "If you are among the 90% of Americans who have health insurance, it’s unlikely to save you much money.",
      "url": "https://finnhub.io/api/news?id=680df2da50e21b1107666dc1a2a060c3ed6ef4767f9bbee22c0d13c5c2777d99"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site",
    "summary": "Roche Holding and AstraZeneca were among those companies posting increases as European pharma stocks tracked gains in the U.S. on Tuesday.",
    "url": "https://finnhub.io/api/news?id=324b961d5138472deb5147bcb763aa73d30c3d5ee04b0dcc736f6f1009e1decb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759309620,
      "headline": "Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site",
      "id": 136944244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Roche Holding and AstraZeneca were among those companies posting increases as European pharma stocks tracked gains in the U.S. on Tuesday.",
      "url": "https://finnhub.io/api/news?id=324b961d5138472deb5147bcb763aa73d30c3d5ee04b0dcc736f6f1009e1decb"
    }
  },
  {
    "ts": null,
    "headline": "Trending tickers: Spotify, Nike, Pfizer, Berkshire Hathaway, Greggs",
    "summary": "US drug deals for Pfizer, CEOs stepping down from Spotify and better-than-expected results for Nike.",
    "url": "https://finnhub.io/api/news?id=818779fa77c0cb48feaa461096e8375b27ffcaa42db7466538f195f7cf36b273",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759308432,
      "headline": "Trending tickers: Spotify, Nike, Pfizer, Berkshire Hathaway, Greggs",
      "id": 136944245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US drug deals for Pfizer, CEOs stepping down from Spotify and better-than-expected results for Nike.",
      "url": "https://finnhub.io/api/news?id=818779fa77c0cb48feaa461096e8375b27ffcaa42db7466538f195f7cf36b273"
    }
  },
  {
    "ts": null,
    "headline": "Shutdown, Tariffs, Pharma Pricing Make for a Busy Start to the Quarter. What Matters.",
    "summary": "Shutdown, Tariffs, Pharma Pricing Make for a Busy Start to the Quarter. What Matters.",
    "url": "https://finnhub.io/api/news?id=c9b98e067bd22edb892d7c5324e127dafe88524ce8ac2af6527836e027d8bc9e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759301160,
      "headline": "Shutdown, Tariffs, Pharma Pricing Make for a Busy Start to the Quarter. What Matters.",
      "id": 136995184,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Shutdown, Tariffs, Pharma Pricing Make for a Busy Start to the Quarter. What Matters.",
      "url": "https://finnhub.io/api/news?id=c9b98e067bd22edb892d7c5324e127dafe88524ce8ac2af6527836e027d8bc9e"
    }
  },
  {
    "ts": null,
    "headline": "Heard on the Street Tuesday Recap: Just What the Doctor Ordered",
    "summary": "The White House unveiled a direct-to-consumer website for Americans to buy discounted drugs.  It wasn't clear whether the website, called TrumpRx, would be useful for the majority of Americans that are already covered by private insurance, Medicare or Medicaid.  Pharmaceutical companies' shares rose.",
    "url": "https://finnhub.io/api/news?id=5c5b4a2232fbfa3fb22db71af59de3e6c7a5cbfd06d1179cae64b80202928674",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759298896,
      "headline": "Heard on the Street Tuesday Recap: Just What the Doctor Ordered",
      "id": 136943920,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The White House unveiled a direct-to-consumer website for Americans to buy discounted drugs.  It wasn't clear whether the website, called TrumpRx, would be useful for the majority of Americans that are already covered by private insurance, Medicare or Medicaid.  Pharmaceutical companies' shares rose.",
      "url": "https://finnhub.io/api/news?id=5c5b4a2232fbfa3fb22db71af59de3e6c7a5cbfd06d1179cae64b80202928674"
    }
  },
  {
    "ts": null,
    "headline": "A government shutdown begins after talks break down",
    "summary": "The first government shutdown in years started Wednesday after lawmakers and President Trump stopped negotiations and focused instead on trying to set up the other side to take the political blame.",
    "url": "https://finnhub.io/api/news?id=fd03c098e7f57f08a43dd4751381887b26695081798ca16b08f983dc3c2bc41e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759291284,
      "headline": "A government shutdown begins after talks break down",
      "id": 136944247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The first government shutdown in years started Wednesday after lawmakers and President Trump stopped negotiations and focused instead on trying to set up the other side to take the political blame.",
      "url": "https://finnhub.io/api/news?id=fd03c098e7f57f08a43dd4751381887b26695081798ca16b08f983dc3c2bc41e"
    }
  },
  {
    "ts": null,
    "headline": "Top Stocks today: Nvidia, Robinhood and Pfizer lead the market",
    "summary": "Here are the stocks that made the biggest moves today",
    "url": "https://finnhub.io/api/news?id=956f65a492a4d39ac1329acbef33fe379dcd855ee88aa4bab79ecfae546e144f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759286517,
      "headline": "Top Stocks today: Nvidia, Robinhood and Pfizer lead the market",
      "id": 136943921,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Here are the stocks that made the biggest moves today",
      "url": "https://finnhub.io/api/news?id=956f65a492a4d39ac1329acbef33fe379dcd855ee88aa4bab79ecfae546e144f"
    }
  }
]